| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| INCYTE CORP | Director | Common Stock | 10.8K | $649K | $59.94 | Jun 12, 2024 | Direct |
| CRISPR Therapeutics AG | Director | Stock Option (Right to Buy) | 13K | May 30, 2024 | Direct | ||
| INCYTE CORP | Director | Non Qualfied Stock Option (right to buy) | 12.5K | Jun 12, 2024 | Direct | ||
| INCYTE CORP | Director | Non-Qualified Stock Option (right to buy) | 11.3K | Jun 14, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| INCY | INCYTE CORP | Jun 12, 2024 | 2 | $0 | 4 | Jun 14, 2024 | Director |
| CRSP | CRISPR Therapeutics AG | May 30, 2024 | 1 | $0 | 4 | May 31, 2024 | Director |
| INCY | INCYTE CORP | Jun 14, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
| CRSP | CRISPR Therapeutics AG | Jun 8, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
| INCY | INCYTE CORP | Jun 15, 2022 | 2 | $0 | 4 | Jun 17, 2022 | Director |
| CRSP | CRISPR Therapeutics AG | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| CRSP | CRISPR Therapeutics AG | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |
| INCY | INCYTE CORP | May 26, 2021 | 2 | $0 | 4 | May 28, 2021 | Director |